Table 4.
Physicochemical characterization of selected LRX formulations.
| Formulation Code | Globule Size (nm ± SD) | PDI | ZP (mV ± SD) |
Viscosity (mPa.s ± SD) | Surface Tension (Dynescm−1) | pH Mean ± SD |
Drug Entrapment Efficiency (%) Mean ± SD |
|---|---|---|---|---|---|---|---|
| LRX-4 | 168.4 ± 43.2 | 0.45 ± 0.03 | −21.18 ± 0.15 | 85.21 ± 2.14 | 56.34 ± 3.04 | 4.73 ± 0.29 | 48.96 ± 5.71 |
| LRX-5 | 125.8 ± 36.5 | 0.25 ± 0.04 | −25.69 ± 0.58 | 62.19 ± 3.18 | 39.59 ± 4.08 | 5.23 ± 0.41 | 62.95 ± 1.90 |
| LRX-6 | 78.6 ± 11.7 | 0.24 ± 0.02 | −29.58 ± 0.61 | 48.47 ± 2.12 | 26.46 ± 2.29 | 5.67 ± 0.45 | 71.91 ± 3.17 |
| LRX-7 | 63.3 ± 15.6 | 0.31 ± 0.06 | −24.48 ± 1.12 | 24.38 ± 3.97 | 35.01 ± 4.77 | 4.47 ± 0.31 | 57.58 ± 6.58 |
| C-LRX | 101.3 ± 24.51 | 0.27 ± 0.04 | +20.29 ± 2.10 | 58.12 ± 5.09 | 31.05 ± 3.57 | 5.95 ± 0.35 | 65.25 ± 4.89 |
Data are expressed as mean ± SD, n = 3.